Clinical Trials Logo

Clinical Trial Summary

Multicentre, national, observational, retrospective and prospective study. The BLITZ-COVID19 study aims at describing the epidemiology of admissions to Italian Cardiology Intensive Care Units in the COVID-19 infection pandemia, the main aspects of the clinical management of inpatients, their short-term outcome, the absorption of resources related to their admission.


Clinical Trial Description

The BLITZ-COVID19 study, aims at describing the epidemiology of admissions to Italian Cardiology Intensive Care Units . The study is observational, multicentre, national and involves the collection of clinical data, both retrospectively and prospectively, using a web-based system. In conducting the study, no drugs are tested, nor are diagnostic tests or non-pharmacological therapies performed other than those that each participating cardiologist decides to perform following the rules of normal clinical practice. Diagnostic procedures and pharmacological and non-pharmacological therapies habitually prescribed for cardiovascular pathologies, which are the object of hospitalization, and those used in the event of a COVID-19 infection, will be recorded in the database. ;


Study Design


Related Conditions & MeSH terms

  • Management and Epidemiology of Patients Admitted in ICU

NCT number NCT04744415
Study type Observational [Patient Registry]
Source Heart Care Foundation
Contact
Status Completed
Phase
Start date November 9, 2020
Completion date March 23, 2021